PatientsVille.com Logo

PatientsVille

Potassium Side Effects

Common Potassium Side Effects


The most commonly reported Potassium side effects (click to view or check a box to report):

Hyperkalaemia (64)
Nausea (46)
Pain (45)
Dyspnoea (43)
Dizziness (42)
Asthenia (41)
Fatigue (37)
Cardiac Arrest (34)
Diarrhoea (32)
Completed Suicide (29)
Renal Failure (28)
Vomiting (28)
Oedema Peripheral (27)
Anxiety (26)
Chest Pain (26)
Pain In Extremity (25)
Muscle Spasms (25)
Fall (24)
Death (24)
Pyrexia (23)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Potassium Side Effects Reported to FDA

The following Potassium reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Potassium on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Flatulence, Abdominal Distension, Local Swelling, Product Substitution Issue, Product Coating Issue
This is a report of a 77-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: blood potassium decreased, who was treated with Potassium Chloride (dosage: 10 Tbcr?1 Pill Twice Daily?twice Daily ?by Mouth, After Food With 8ozs. Ivater, start time: Sep 10, 2013), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Flatulence
  • Abdominal Distension
  • Local Swelling
  • Product Substitution Issue
  • Product Coating Issue
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Potassium Chloride treatment in female patients, resulting in flatulence side effect. The patient was hospitalized and became disabled.

Amniotic Cavity Infection, Tachycardia, Body Temperature Increased, Premature Labour, Premature Rupture Of Membranes, Breech Presentation, Maternal Exposure During Pregnancy
This report suggests a potential Potassium Chloride Amniotic Cavity Infection, Tachycardia, Body Temperature Increased, Premature Labour, Premature Rupture Of Membranes, Breech Presentation, Maternal Exposure During Pregnancy side effect(s) that can have serious consequences. A 18-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Potassium Chloride (dosage: NA) starting NS. Soon after starting Potassium Chloride the patient began experiencing various side effects, including:
  • Amniotic Cavity Infection
  • Tachycardia
  • Body Temperature Increased
  • Premature Labour
  • Premature Rupture Of Membranes
  • Breech Presentation
  • Maternal Exposure During Pregnancy
Drugs used concurrently:
  • Doxycycline (200 Mg, Every 12 Hours)
  • Ticarcillin (3.1 G, Every 6 Hours)
  • Clavulanate Potassium
  • Oxytocin
Although Potassium Chloride demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as amniotic cavity infection, may still occur.

Unresponsive To Stimuli, Cardio-respiratory Arrest, Pulseless Electrical Activity, Alkalosis, Acidosis, Hyperkalaemia
This Unresponsive To Stimuli, Cardio-respiratory Arrest, Pulseless Electrical Activity, Alkalosis, Acidosis, Hyperkalaemia problem was reported by a pharmacist from US. A 68-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: hypokalaemia. On Jan 21, 2014 this consumer started treatment with Potassium Chloride (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Potassium Chloride, the patient experienced the following unwanted symptoms/side effects:
  • Unresponsive To Stimuli
  • Cardio-respiratory Arrest
  • Pulseless Electrical Activity
  • Alkalosis
  • Acidosis
  • Hyperkalaemia
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as unresponsive to stimuli, may become evident only after a product is in use by the general population.

Pulseless Electrical Activity, Cardiac Arrest, Hyperkalaemia, Bradycardia
This is a report of a 85-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: electrolyte imbalance,cardiac failure congestive and was treated with Potassium Chloride (dosage: 5 Packages Of 20 Meq; J-tube (jejunostomy Tube)) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Pulseless Electrical Activity
  • Cardiac Arrest
  • Hyperkalaemia
  • Bradycardia
The patient was hospitalized. This opens a possibility that Potassium Chloride treatment could cause the above reactions, including pulseless electrical activity, and some female subjects may be more susceptible.


Abdominal Pain Upper, Nausea
A 61-year-old female patient (weight: NA) from COUNTRY NOT SPECIFIED with the following symptoms/conditions: NA started Potassium treatment (dosage: 20 Meq 2 Packets Once A Day) on Jan 02, 2013. Soon after starting Potassium treatment, the subject experienced various side effects, including:
  • Abdominal Pain Upper
  • Nausea
Concurrently used drugs:
  • Prednisone (5mg 4 Tablets Once A Day)
  • Propranolol (20mg 1 Tablet Twice A Day)
  • Metronidazole
  • Lipitor
  • Metoprolol
  • Humira
  • Lansoprazole (30mg 2 Tablets Once A Day)
  • Mesalamine (250mg 4 Capsules Three Times A Day)
This finding indicates that some female patients could be more vulnerable to Potassium.

Product Quality Issue, Throat Irritation, Amnesia
A 81-year-old female patient from US (weight: NA) experienced symptoms, such as: muscle spasms and was treated with Potassium Cl(dosage: 2 Caps Once Daily (with Food) By Mouth ( 1 Take It With Breaksast)(including Hot Coffee)). The treatment was initiated on Sep 08, 2013. After that a consumer reported the following side effect(s):
  • Product Quality Issue
  • Throat Irritation
  • Amnesia
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Potassium Cl efficacy:
  • Omeprazole
  • Diphenoxylate/atropine
  • Furosemide
  • Glucosamine
  • Multivitamin
  • B-complex
  • Fish Oil
  • Calcium


Blister, Skin Lesion
In this report, Potassium Chloride Oral Solution .10 was administered for the following condition: NA.A 12-year-old male consumer from US (weight: NA) started Potassium Chloride Oral Solution .10 treatment (dosage: 10%, 3.75ml (5meq) Diluted In 10ml Of Water) on NS.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Blister
  • Skin Lesion
A possible interaction with other drugs could have contributed to this reaction: NA.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Potassium Chloride Oral Solution .10 treatment could be related to the listed above side effect(s).

Hyperkalaemia
This is a report of the following Potassium Chloride side effect(s):
  • Hyperkalaemia
A 90-year-old male patient from US (weight: NA) presented with the following condition: hypokalaemia and received a treatment with Potassium Chloride (dosage: 1 Pill Qd Oral) starting: NS.The following concurrently used drugs could have generated interactions:
  • Aspirin
  • Atenolol
  • Oyster Shell Calcium-vitamin D3
The patient was hospitalized.This report suggests that a Potassium Chloride treatment could be associated with the listed above side effect(s).

Large Intestinal Obstruction, Product Substitution Issue
This Potassium report was submitted by a 86-year-old female consumer from US (weight: NA). The patient was diagnosed with: NA and Potassium was administered (dosage: 1 Tablet) starting: Oct 14, 2013. The consumer developed a set of symptoms:
  • Large Intestinal Obstruction
  • Product Substitution Issue
Other drugs used simultaneously:
  • Matopalon
  • Adver
  • Spanva
Those unexpected symptoms could be linked to a Potassium treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pain, Joint Swelling, Abasia, Sensation Of Heaviness, Local Swelling
This is a report of a possible correlation between Potassium use and the following symptoms/side effect(s):
  • Pain
  • Joint Swelling
  • Abasia
  • Sensation Of Heaviness
  • Local Swelling
which could contribute to an assessment of Potassium risk profile.A female consumer from US (weight: NA) was suffering from NA and was treated with Potassium (dosage: 10 Nieq 2 Pills Twice Daily By Mouth) starting Nov 29, 2013.Other concurrent medications:
  • Hydrochorothiazide
  • Oyster Shell
  • Alendronate Sodium
  • Naproxen Pain + Fever
The patient was hospitalized and became disabled.

Hyperkalaemia
A 61-year-old male patient from US (weight: NA) presented with the following symptoms: hypokalaemia and after a treatment with Potassium Chloride (dosage: 20 Meq Bid Po) experienced the following side effect(s):
  • Hyperkalaemia
The treatment was started on Jun 18, 2011. Potassium Chloride was used in combination with the following drugs:
  • Spironolactone
The patient was hospitalized.This report could alert potential Potassium Chloride consumers.

Device Occlusion, Device Alarm Issue, No Adverse Event
In this report, a 4-year-old female patient from US (weight: NA) was affected by a possible Potassium Chloride In Sodium Chloride side effect.The patient was diagnosed with NA. After a treatment with Potassium Chloride In Sodium Chloride (dosage: NA, start date: Dec 12, 2013), the patient experienced the following side effect(s):
  • Device Occlusion
  • Device Alarm Issue
  • No Adverse Event
The following simultaneously used drugs could have led to this reaction:
  • Dextrose
  • Ketamine
  • Dilaudid
The findings here stress that side effects should be taken into consideration when evaluating a Potassium Chloride In Sodium Chloride treatment.

Hypersensitivity
This is a report of a 66-year-old female patient from US (weight: NA), who used Potassium Chloride Extended-release (watson Laboratories) (dosage: NA) for a treatment of NA. After starting a treatment on NS, the patient experienced the following side effect(s):
  • Hypersensitivity
The following drugs could possibly have interacted with the Potassium Chloride Extended-release (watson Laboratories) treatment NA.Taken together, these observations suggest that a Potassium Chloride Extended-release (watson Laboratories) treatment could be related to side effect(s), such as Hypersensitivity.

Oral Pain, Excoriation, Laryngeal Disorder, Retching, Oropharyngeal Pain, Product Physical Issue, Product Quality Issue
This oral pain side effect was reported by a consumer or non-health professional from US. A 74-year-old female patient (weight:NA) experienced the following symptoms/conditions: hypokalaemia. The patient was prescribed Potassium Chloride (dosage: NA), which was started on Sep 17, 2013. Concurrently used drugs: NA. When starting to take Potassium Chloride the consumer reported the following symptoms:
  • Oral Pain
  • Excoriation
  • Laryngeal Disorder
  • Retching
  • Oropharyngeal Pain
  • Product Physical Issue
  • Product Quality Issue
These side effects may potentially be related to Potassium Chloride.

Hypokalaemia, Fatigue
This is a Potassium Chloride side effect report of a 63-year-old male patient (weight:NA) from IT, suffering from the following symptoms/conditions: NA, who was treated with Potassium Chloride (dosage:NA, start time: Sep 26, 2013), combined with:
  • Ramipril (1 Df, Qd)
  • Kanrenol (200 Mg, Qd)
  • Ferro-grad (105 Mg)
  • Bisoprolol (2.5 Mg)
  • Atorvastatin (20 Mg)
  • Dorzolamide
  • Timolol
  • Insulin Lispro (30 U)
, and developed a serious reaction and a hypokalaemia side effect. The patient presented with:
  • Hypokalaemia
  • Fatigue
which developed after the beginning of treatment. The patient was hospitalized. This side effect report can indicate a possible existence of increased vulnerability to Potassium Chloride treatment in male patients suffering from NA, resulting in hypokalaemia.

Hyperkalaemia, Ventricular Fibrillation, Pulseless Electrical Activity, Electrocardiogram St Segment Elevation, Electrocardiogram Qrs Complex Prolonged, Overdose
This report suggests a potential Potassium Chloride Extended-release (watson Laboratories) hyperkalaemia side effect(s) that can have serious consequences. A 56-year-old male patient from HU (weight:NA) was diagnosed with the following health condition(s): overdose and used Potassium Chloride Extended-release (watson Laboratories) (dosage: }50 G, Single) starting NS. Soon after starting Potassium Chloride Extended-release (watson Laboratories) the patient began experiencing various side effects, including:
  • Hyperkalaemia
  • Ventricular Fibrillation
  • Pulseless Electrical Activity
  • Electrocardiogram St Segment Elevation
  • Electrocardiogram Qrs Complex Prolonged
  • Overdose
Drugs used concurrently:NA. The patient was hospitalized. Although Potassium Chloride Extended-release (watson Laboratories) demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as hyperkalaemia, may still occur.

Renal Failure
This renal failure problem was reported by a consumer or non-health professional from US. A 70-year-old female patient (weight: NA) was diagnosed with the following medical condition(s): electrolyte imbalance.On 2008 a consumer started treatment with Potassium Chloride Extended-release (watson Laboratories) (dosage: 20 Meq, Bid). The following drugs/medications were being taken at the same time:
  • Magnesium (Daily)
  • Neurontin (Daily)
When commencing Potassium Chloride Extended-release (watson Laboratories), the patient experienced the following unwanted symptoms /side effects:
  • Renal Failure
The patient was hospitalized. Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as renal failure, may become evident only after a product is in use by the general population.

Renal Failure, Dehydration
This is a Potassium Chloride side effect report of a 70-year-old female patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Potassium Chloride (dosage: NA) starting NS. Concurrently used drugs:
  • Magnesium (magnesium)
  • Neurontin (gabapentin)
  • Vitamin D3 (colecalciferol)
Soon after that, the consumer experienced the following of symptoms:
  • Renal Failure
  • Dehydration
The patient was hospitalized. This opens a possibility that Potassium Chloride could cause renal failure and that some female patients may be more susceptible.

Extravasation, Skin Necrosis
A 56-year-old female patient (weight: NA) from FR with the following symptoms: hypokalaemia started Potassium Chloride treatment (dosage: 1 In 6 Hrs) on May 24, 2013. Soon after starting Potassium Chloride treatment, the consumer experienced several side effects, including:
  • Extravasation
  • Skin Necrosis
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Potassium Chloride side effects, such as extravasation.

Supraventricular Tachycardia, Grand Mal Convulsion, Nodal Rhythm, Pyrexia, Hypotension
This death side effect was reported by a pharmacist from US. A 54-year-old patient (weight:NA) experienced the following symptoms/conditions: NA.The patient was prescribed Potassium Chloride In 5% Dextrose And Sodium Chloride Injection , Usp (dosage: NA), which was started on Oct 04, 2013. Concurrently used drugs:
  • Levophed
  • Levophed
  • Levophed
  • Aspirin
  • Tylenol
.When starting to take Potassium Chloride In 5% Dextrose And Sodium Chloride Injection , Usp the consumer reported symptoms, such as:
  • Supraventricular Tachycardia
  • Grand Mal Convulsion
  • Nodal Rhythm
  • Pyrexia
  • Hypotension
These side effects may potentially be related to Potassium Chloride In 5% Dextrose And Sodium Chloride Injection , Usp.

Urticaria, Palpitations, Dysphonia
This is a report of a 84-year-old female patient (weight: NA) from US, suffering from the following symptoms/conditions: NA, who was treated with Potassium Chloride Micro-dispersible (dosage: 100 Meq, Qd, start time: Jan 11, 2013), combined with:
  • Xanax (Unk)
  • Vitamin B12 /00056201/ (Unk)
  • Levothyroxine (Unk)
  • Edecrin /00020501/ (Unk)
and developed a serious reaction and side effect(s). The consumer presented with:
  • Urticaria
  • Palpitations
  • Dysphonia
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Potassium Chloride Micro-dispersible treatment in female patients, resulting in urticaria side effect.

Product Quality Issue, Product Physical Issue
This report suggests a potential Potassium Product Quality Issue, Product Physical Issue side effect(s) that can have serious consequences. A 81-year-old male patient (weight: NA) from US was diagnosed with the following symptoms/conditions: NA and used Potassium (dosage: 1 Tablet) starting NS. Soon after starting Potassium the patient began experiencing various side effects, including:
  • Product Quality Issue
  • Product Physical Issue
Drugs used concurrently:
  • Ranitidine (1 Tablet)
Although Potassium demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as product quality issue, may still occur.

Respiratory Failure, Tachycardia, Hypertension
This Respiratory Failure, Tachycardia, Hypertension problem was reported by a health professional from PT. A 62-year-old male patient (weight: NA) was diagnosed with the following symptoms/conditions: NA. On NS this consumer started treatment with Potassium Chloride (dosage: NA). The following drugs were being taken at the same time:
  • Bupivacaine
  • Bupivacaine
  • Fentanyl
  • Fentanyl
When commencing Potassium Chloride, the patient experienced the following unwanted symptoms/side effects:
  • Respiratory Failure
  • Tachycardia
  • Hypertension
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as respiratory failure, may become evident only after a product is in use by the general population.

Hyperkalaemia, Bradycardia, Hypotension, Depressed Level Of Consciousness, Acute Respiratory Failure
This is a report of a 65-year-old male patient (weight: NA) from US. The patient developed the following symptoms/conditions: NA and was treated with Potassium Chloride (dosage: NA) starting NS. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Hyperkalaemia
  • Bradycardia
  • Hypotension
  • Depressed Level Of Consciousness
  • Acute Respiratory Failure
The patient was hospitalized. This opens a possibility that Potassium Chloride treatment could cause the above reactions, including hyperkalaemia, and some male subjects may be more susceptible.

Infusion Site Pain, Vein Disorder, Discomfort
A male patient (weight: NA) from US with the following symptoms/conditions: NA started Potassium Chloride In Sodium Chloride treatment (dosage: 10 Meq/100 Ml) on NS. Soon after starting Potassium Chloride In Sodium Chloride treatment, the subject experienced various side effects, including:
  • Infusion Site Pain
  • Vein Disorder
  • Discomfort
Concurrently used drugs: NA. This finding indicates that some male patients could be more vulnerable to Potassium Chloride In Sodium Chloride.

1 of 37 



Top 10 Potassium Side Effects for Women

Women Side EffectsReports
Pain 35
Nausea 33
Dizziness 30
Dyspnoea 25
Chest Pain 24
Fatigue 24
Pain In Extremity 23
Asthenia 20
Diarrhoea 20
Muscle Spasms 20

Top 10 Potassium Side Effects for Men

Men Side EffectsReports
Hyperkalaemia 46
Asthenia 21
Dyspnoea 18
Death 13
Fatigue 13
Nausea 13
Renal Failure 13
Dizziness 12
Diarrhoea 11
Pyrexia 11

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Potassium Side Effects

    Did You Have a Potassium Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Potassium for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Potassium Safety Alerts, Active Ingredients, Usage Information

    NDC0054-0123
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameLosartan Potassium
    NameLosartan Potassium
    Dosage FormTABLET
    RouteORAL
    On market since20101006
    LabelerRoxane Laboratories, Inc.
    Active Ingredient(s)LOSARTAN POTASSIUM
    Strength(s)25
    Unit(s)mg/1
    Pharma ClassAngiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC]

    More About Potassium

    Side Effects reported to FDA: 913

    Potassium safety alerts: 2013 2008

    Reported deaths: 103

    Reported hospitalizations: 274

    20 mEq Potassium Chloride in 5 Percent Dextrose and 0.45 Percent Sodium Chloride Injection, USP

    Audience: Hospital pharmacists, hospital risk managers, other healthcare professionals

    [Posted 12/09/2008] Hospira, Inc. notified healthcare professionals of a recall of one lot (lot number 65-620-FW, expiration date May 1, 2010, NDC 0409-7902-09) of 20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP in 1000 mL flexible plastic containers. A small number of the containers may be incorrectly labeled with a bar code for 5% Dextrose Injection, USP (NDC 0409-7922-09). The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication. Potential adverse events related to an error of this type include electrolyte imbalance, cardiac dysfunction, gastrointestinal disturbances, paresthesia and mental confusion. The affected lot was shipped to U.S. customers between July 2008 and September 2008. Healthcare facilities with an existing inventory should quarantine the product immediately and call Hospira Customer Care at 1-877-946-7747 for instructions on how to return it.

    [December 08, 2008 - Press Release - Hospira, Inc.]

    Latest Potassium clinical trials